Congress website | https://web.cvent.com/event/a6cd0d72-4b4e-40a4-939b- c133c05df3af/summary |
Abstract guidelines | https://web.cvent.com/event/a6cd0d72-4b4e-40a4-939b- c133c05df3af/websitePage:795426fe-0fc9-44d7-9156-b30723c39052 |
Submission category | • Genetics• Nucleic Acids in SLE• The Macrophage in SLE• Lupus Nephritis• Brain Injury in SLE• Pharmacoepidemiology• Clinical Research in SLE• Covid-19• Cutaneous SLE• SLE Diagnosis• Lupus-Targeted Therapeutics• Cardiovascular Disease and Lupus• PROs• Biomarkers in Clinical Trials• B Cells• Transcriptomics• T Cells• Innate Immunity• Autoantibodies• Microbiome |
Presentation preference | N/A |
Character/word limit | No limit stated, will ask congress to confirm |
Figures/tables | Allowed- No limit stated, will ask congressEmbed in abstract word doc |
References | N/A |
Style | |
Other points | A lay summary is required – see separate Lay summary file |
Disclosures | Not needed at submission |
Other | |
Submission deadline | August 1, 2022 at 11:59 PM ET |